Drugmaker Eli Lilly announced that the FDA approved its daily GLP-1 pill, which will be marketed under the name Foundayo, to treat obesity
The findings were published in January 2024 and indicated the FDA did not find a link between the use of Saxenda, Wegovy or Zepbound and an increase in suicidal ideations
The follow-up results indicated that patients who underwent TORe achieved a 3.5% total weight loss (TWL), a statistically significant improvement over the 0.4% TWL observed in the control group that received a sham procedure ( p = 0.02) after 1 year (69)
Fournier's Gangrene: An extremely rare but life-threatening bacterial infection affecting the genital area or perineum
Research has shown that GHRH analogs combined with ghrelin mimetics can produce GH pulses 3 to 5 times greater than either peptide by itself
Finally, another element in these scams is the missing or fake shipments, where consumers order a product that never comes